1. Home
  2. CNTX vs THCH Comparison

CNTX vs THCH Comparison

Compare CNTX & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • THCH
  • Stock Information
  • Founded
  • CNTX 2015
  • THCH 2018
  • Country
  • CNTX United States
  • THCH China
  • Employees
  • CNTX N/A
  • THCH N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • THCH Blank Checks
  • Sector
  • CNTX Health Care
  • THCH Finance
  • Exchange
  • CNTX Nasdaq
  • THCH Nasdaq
  • Market Cap
  • CNTX 78.0M
  • THCH 84.8M
  • IPO Year
  • CNTX 2021
  • THCH N/A
  • Fundamental
  • Price
  • CNTX $0.58
  • THCH $2.77
  • Analyst Decision
  • CNTX Strong Buy
  • THCH
  • Analyst Count
  • CNTX 4
  • THCH 0
  • Target Price
  • CNTX $6.00
  • THCH N/A
  • AVG Volume (30 Days)
  • CNTX 390.0K
  • THCH 14.0K
  • Earning Date
  • CNTX 08-06-2025
  • THCH 06-24-2025
  • Dividend Yield
  • CNTX N/A
  • THCH N/A
  • EPS Growth
  • CNTX N/A
  • THCH N/A
  • EPS
  • CNTX N/A
  • THCH N/A
  • Revenue
  • CNTX N/A
  • THCH $190,593,061.00
  • Revenue This Year
  • CNTX N/A
  • THCH N/A
  • Revenue Next Year
  • CNTX N/A
  • THCH N/A
  • P/E Ratio
  • CNTX N/A
  • THCH N/A
  • Revenue Growth
  • CNTX N/A
  • THCH N/A
  • 52 Week Low
  • CNTX $0.49
  • THCH $2.15
  • 52 Week High
  • CNTX $2.75
  • THCH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 44.00
  • THCH 50.83
  • Support Level
  • CNTX $0.56
  • THCH $2.58
  • Resistance Level
  • CNTX $0.63
  • THCH $2.75
  • Average True Range (ATR)
  • CNTX 0.08
  • THCH 0.13
  • MACD
  • CNTX 0.00
  • THCH 0.00
  • Stochastic Oscillator
  • CNTX 27.68
  • THCH 45.56

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About THCH TH International Limited Ordinary shares

TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.

Share on Social Networks: